Login

Inhibrx, Inc. 4 SEC Filings

Filed On Filing
03 Jun 2024 Form 4: Viking Global Investors Lp, 10% owner and 7 others

Disposed of 7,150,826 shares (Other Transaction) ($215M) · Disposed of 1,038,765 Warrants (right to buy) (Other Transaction) ($31.2M)

31 May 2024 Form 4: Inhibrx, Inc., 10% owner · Inhibrx Biosciences Inc

Disposed of 13,316,140 shares (Other Transaction)

30 May 2024 Form 4: Vuori Kristiina Md, Director

Disposed of 60,000 Stock Option (right to buy) (Disposition to Issuer)

30 May 2024 Form 4: Manhard Kimberly, Director

Disposed of 65,759 Stock Option (right to buy) (Disposition to Issuer)

30 May 2024 Form 4: Lappe Mark, Director

Returned 3,045,654 shares to the issuer ($91.4M) · Disposed of 245,000 Stock Option (right to buy) (Disposition to Issuer)

30 May 2024 Form 4: Kayyem Jon Faiz, Director

Returned 3,274,301 shares to the issuer ($98.2M) · Disposed of 62,259 Stock Option (right to buy) (Disposition to Issuer)

30 May 2024 Form 4: Forsyth Douglas, Director

Returned 598,257 shares to the issuer ($17.9M) · Disposed of 62,259 Stock Option (right to buy) (Disposition to Issuer)

30 May 2024 Form 4: Eckelman Brendan P., Chief Scientific Officer

Sold 300,000 shares ($10.3M) · Returned 2,055,553 shares to the issuer ($61.7M) · Disposed of 33,334 Stock Option (right to buy) (Disposition to Issuer)

30 May 2024 Form 4: Deck Kelly, Chief Financial Officer

Disposed of 45,000 Stock Option (right to buy) (Disposition to Issuer)

24 May 2024 Form 4: Eckelman Brendan P., Chief Scientific Officer

Exercised 5,010 Stock Option (right to buy) ($171K)

08 May 2024 Form 4: Deck Kelly, Chief Financial Officer

Exercised 19,711 Stock Option (right to buy) ($675K)

28 Mar 2024 Form 4: Deck Kelly, Chief Financial Officer

Exercised 2,896 Stock Option (right to buy) ($103K)

22 Mar 2024 Form 4: Deck Kelly, Chief Financial Officer

Exercised 16,777 Stock Option (right to buy) ($588K) · Exercised 3,113 Stock Option (right to buy) ($109K) · Exercised 110 Stock Option (right to buy) ($3.85K)

15 Mar 2024 Form 4: Eckelman Brendan P., Chief Scientific Officer

Exercised 1,898 Stock Option (right to buy) ($67.1K)

15 Mar 2024 Form 4: Deck Kelly, Chief Financial Officer

Exercised 32,431 Stock Option (right to buy) ($1.15M)

12 Mar 2024 Form 4: Eckelman Brendan P., Chief Scientific Officer

Exercised 2,150 Stock Option (right to buy) ($76.9K) · Exercised 13,558 Stock Option (right to buy) ($479K) · Exercised 24,050 Stock Option (right to buy) ($848K)

12 Mar 2024 Form 4: Deck Kelly, Chief Financial Officer

Exercised 42,523 Stock Option (right to buy) ($1.52M)

06 Mar 2024 Form 4: Deck Kelly, Chief Financial Officer

Exercised 62,083 Stock Option (right to buy) ($2.2M) · Exercised 10,417 Stock Option (right to buy) ($372K)

30 Aug 2023 Form 4: Viking Global Investors Lp, 10% owner and 5 others

Bought 511,627 shares ($9.9M) · Acquired 1,038,765 Warrants (right to buy) (Open Market Purchase) ($20.1M)

30 May 2023 Form 4: Forsyth Douglas, Director

Granted 15,000 Stock Option (right to buy)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support